Deal Team

Corporate

Dentsply Sirona in its review of strategic alternatives for Wellspect Healthcare

On February 11, 2025, Dentsply Sirona (Nasdaq: XRAY) announced that it has initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business.  Wellspect is a leading provider of continence care products with an over 40-year history.

Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Dentsply Sirona.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.